ALCAM regulates multiple myeloma chemoresistant side population

Drug-resistance is a major problem preventing a cure in patients with multiple myeloma (MM). Previously, we demonstrated that activated-leukocyte-cell-adhesion-molecule (ALCAM) is a prognostic factor in MM and inhibits EGF/EGFR-initiated MM clonogenicity. In this study, we further showed that the AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fangfang, Dan, Zhang, Luo, Hongmei, Huang, Jingcao, Cui, Yushan, Ding, Hong, Xu, Juan, Lin, Zhimei, Gao, Yuhan, Zhai, Xinyu, Yang, Yan, Qu, Ying, Zhang, Li, Chen, Fengjiao, Wang, Qiang, Wang, Xin, Feng, Yu, Liu, Ting, Yi, Qing, Niu, Ting, Zheng, Yuhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831486/
https://www.ncbi.nlm.nih.gov/pubmed/35145058
http://dx.doi.org/10.1038/s41419-022-04556-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831486/
https://www.ncbi.nlm.nih.gov/pubmed/35145058
http://dx.doi.org/10.1038/s41419-022-04556-8

Ejemplares similares